NOLUDAR Drug Patent Profile
✉ Email this page to a colleague
When do Noludar patents expire, and what generic alternatives are available?
Noludar is a drug marketed by Roche and is included in one NDA.
The generic ingredient in NOLUDAR is methyprylon. Additional details are available on the methyprylon profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NOLUDAR?
- What are the global sales for NOLUDAR?
- What is Average Wholesale Price for NOLUDAR?
Summary for NOLUDAR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 15 |
| Patent Applications: | 1,560 |
| DailyMed Link: | NOLUDAR at DailyMed |
US Patents and Regulatory Information for NOLUDAR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | NOLUDAR | methyprylon | CAPSULE;ORAL | 009660-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | NOLUDAR | methyprylon | ELIXIR;ORAL | 009660-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | NOLUDAR | methyprylon | TABLET;ORAL | 009660-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
